Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
12:00 AM - DEVICE TALKS
9
11
12
13
14
16
18
19
20
21
22
23
24
26
27
28
29
30
31
1
2
3
4
DEVICE TALKS
DEVICE TALKS BOSTON 2018: BIGGER AND BETTER THAN EVER! Join us Oct. 8-10 for the 7th annual DeviceTalks Boston, back in the city where it [...]
6th Annual HealthIMPACT Midwest
2018-10-10    
All Day
REV1 VENTURES COLUMBUS, OH The Provider-Patient Experience Summit - Disrupting Delivery without Disrupting Care HealthIMPACT Midwest is focused on technologies impacting clinician satisfaction and performance. [...]
15 Oct
2018-10-15 - 2018-10-16    
All Day
Conference Series Ltd invites all the participants from all over the world to attend “3rd International Conference on Environmental Health” during October 15-16, 2018 in Warsaw, Poland which includes prompt keynote [...]
17 Oct
2018-10-17 - 2018-10-19    
7:00 am - 6:00 pm
BALANCING TECHNOLOGY AND THE HUMAN ELEMENT In an era when digital technologies enable individuals to track health statistics such as daily activity and vital signs, [...]
Epigenetics Congress 2018
2018-10-25 - 2018-10-26    
All Day
Conference: 5th World Congress on Epigenetics and Chromosome Date: October 25-26, 2018 Place: Istanbul, Turkey Email: epigeneticscongress@gmail.com About Conference: Epigenetics congress 2018 invites all the [...]
Events on 2018-10-08
DEVICE TALKS
8 Oct 18
425 Summer Street
Events on 2018-10-10
Events on 2018-10-17
17 Oct
Events on 2018-10-25
Epigenetics Congress 2018
25 Oct 18
Istanbul
Articles News

A study shows that AI can detect suicide risk early.

EMR Industry

As artificial intelligence helps doctors discover diseases like cancer at an early stage, it is also demonstrating its potential in tackling mental health crises. According to one study, artificial intelligence can detect patients who are at danger of suicide, providing a tool for prevention in everyday medical settings.

The study, published in the JAMA Network Open Journal, examined two approaches of notifying doctors about suicide risk: an active “pop-up” alarm demanding immediate attention and a passive system (less urgent) that displays risk information in a patient’s electronic chart.

The study discovered that active warnings beat the passive strategy, encouraging doctors to assess suicide risk in 42% of cases, against only 4% with the passive system. Furthermore, it emphasized the importance of using certain techniques to initiate a discourse about suicide risks.

This breakthrough, which combines automated risk identification with deliberately tailored alarms, provides hope for identifying and supporting more people in need of suicide prevention services.

Colin Walsh, an Associate Professor of Biomedical Informatics, Medicine, and Psychiatry at Vanderbilt University Medical Center, emphasized the importance of this breakthrough. “Most people who die by suicide have seen a healthcare provider in the year before their death, often for reasons unrelated to mental health,” according to Walsh.

Previous research indicates that 77% of people who commit suicide had contact with primary care doctors in the year before their death. These findings highlight the essential role AI can play in bridging the gap between conventional medical treatment and mental health interventions.

The Suicide Attempt and Ideation Likelihood model (VSAIL), an AI-driven system developed at Vanderbilt, was tested in three neurology clinics. The method uses normal data from electronic health records to calculate a patient’s 30-day probability of attempting suicide. When high-risk patients were identified, practitioners were encouraged to start focused conversations about mental health.

Walsh clarified: “Universal screening isn’t practical everywhere, but VSAIL helps us focus on high-risk patients and spark meaningful screening conversations.”

While the findings were promising, the researchers emphasized the importance of striking a balance between the benefits of active alerts and their possible drawbacks, such as workflow disruption. The authors proposed that comparable methods may be implemented for other medical specialties in order to broaden their reach and impact.

Cambridge University published a research earlier in 2022 that used PRISMA criteria to assess individuals who were at risk of attempting suicide.